发明名称 COMBINATION TYPE NEWCASTLE DISEASE VIRUS VACCINE
摘要 <p>PROBLEM TO BE SOLVED: To prepare the subject vaccine, comprising a specific heterologous vector and a live Newcastle disease virus(NDV) vaccine strain as active ingredients, capable of systemically and locally arousing immune reaction due to synergistic actions and effective against infection with the NDV. SOLUTION: This combination type Newcastle disease viral vaccine comprises (A) a heterologous vector capable of expressing (i) an NDV immunogen subunit or (ii) an NDV immunogen protein (preferably a live virus vector) as the first active ingredient and further (B) a live NDV vaccine strain. The ingredient (i) is an expression product of an insect cell expression system, especially that of a recombinant baculovirus and the ingredient A is a herpes virus of turkeys (HVT) or a fowlpox virus(FPV). The ingredient B is a low toxic NDV strain having a long latent period and a C2 strain deposited with the CNCM of the Institut Pasteur as a stipulation No. I-1614.</p>
申请公布号 JPH09169663(A) 申请公布日期 1997.06.30
申请号 JP19960276356 申请日期 1996.10.18
申请人 AKZO NOBEL NV 发明人 KARURA KURISUTEINA SURIERU;HAINRIHI DEIITAA RIYUTEITSUKEN
分类号 C12N15/09;A61K39/00;A61K39/17;A61P31/12;C07K14/03;C07K14/125;C12P7/04;(IPC1-7):A61K39/17 主分类号 C12N15/09
代理机构 代理人
主权项
地址